Carolina Molecular
Your Trusted Partner in Advanced Molecular Testing & Analysis
Molecular Expertise that Evolves with Science
With a legacy spanning 25 years, Carolina Molecular Inc builds upon the pedigree of Gentris, Cancer Genetics, and Flagship Biosciences to deliver cutting-edge molecular testing services. We partner with CROs/CDMOs, CGT innovators, technology providers, and research institutions to extend the breadth and depth of their offerings, enabling breakthroughs in clinical diagnostics, discovery research, and product development.
A Unified Platform for Molecular Testing Solutions
Modern life science requires specialized workflows, not generalist solutions. We provide a seamless interface for complex molecular projects, delivering dedicated support across:
Clinical Testing
CLIA-certified and CAP- accredited workflows to support your diagnostic development.
NGS Foundry
Flexible, scalable sequencing solutions designed for speed and data integrity.
Bioinformatics
Custom pipelines to untangle complex datasets, delivering clear, publication-ready insights.
Powered by Best-in-Class Technology
We believe the best science requires the best tools. We maintain strategic partnerships with the industry’s leading technology providers to ensure you have access to the latest sequencing chemistries and platforms.
Remove hardware bottlenecks. We utilize kinetic, instrument-free workflows to deliver scalable, high-quality scRNA-seq data for any sample type.
Map cell surface proteins in 3D using Molecular Pixelation (MPX). Gain high-resolution immunological insights without the need for complex microscopy.
See biology in context. We leverage advanced phenotypic assays to characterize complex cellular models and validate drug responses with visual data.
Advanced Molecular Analysis Capabilities
Sample Extraction & Library Prep
- Blood
- Tissue
- FFPE
- Cells
- Biobanking and sample storage
Expression Profiling
- GeoMx Spatial
- Single-cell RNAseq
- RNAseq
- nCounter
Genomic Analysis
- Germline Sequencing
- Microbiome
- Epigenetics
- Minimal Residual Disease (MRD)
Why Partner with Carolina Molecular?
Trustworthy Expertise
- CAP/CLIA certified since 2017
- USDA APHIS permitted facility
- Over 50 validated molecular assays
- Supporting more than 200 clients
Hassle-Free Sequencing
- Transparent pricing and scheduling
- Rapid quote turnaround
- Direct communication with scientific team
- Primary analytics included
- Operated under established QMS
State-of-the-Art Technology
- Illumina NovaSeqX Plus for high-throughput applications
- NextSeq and MiSeq platforms for targeted applications
- Advanced QPCR and Sanger sequencing capabilities
Comprehensive Analytics
- Primary, secondary, and tertiary analysis available
- Integrating NGS with other spatial data
- Specialized services tailored for clinical trials, discovery, and characterization projects
Local courier service available at no charge
Ready to Enhance Your Capabilities?
Contact us today to discuss how Carolina Molecular can amplify your molecular testing capabilities and streamline your clinical, translational, and research projects.